|
Current issue
Archive
Videos
Articles in press
About the journal
Supplements
Editorial board
Reviewers
Abstracting and indexing
Subscription
Contact
Instructions for authors
Publication charge
Ethical standards and procedures
Editorial System
Submit your Manuscript
|
2/2005
vol. 107 abstract:
Review paper
The present role of prostaglandin analogues in the medical treatment of glaucoma
Joanna Wierzbowska
1
,
Marek Rękas
1
,
Daria Malawko
1
Klinika Oczna 2005, 107(4-6): 312-315
Online publish date: 2005/07/02
View
full text
Get citation
ENW EndNote
BIB JabRef, Mendeley
RIS Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
Therapy with prostaglandin analogues (PGA), a novel class of intraocular-lowering medications, represents a safe and very effective pharmacologic method of treating patients with glaucoma and ocular hypertension. The convince dosing regimen, once-daily, higher efficacy and higher systemic safety profile seen with PGA compared with betablockers caused that these agents have been approved by regulatory bodies for both the first-line and adjunctive therapy. Short, retrospective analysis of the medical treatment of glaucoma in the Ophthalmology Clinic of Military Health Service Institute in Warsaw, in 2003-2004, was presented.
keywords:
the medical treatment of glaucoma, the first-line therapy, the adjunctive therapy, prostaglandin analogues, safety profile of the treatment |
|
POLSKI
